Natera, Inc. Product revenues — Cost of revenues increased by 11.8% to $245.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.8%, from $184.61M to $245.20M. Over 4 years (FY 2021 to FY 2025), Product revenues — Cost of revenues shows an upward trend with a 27.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease relative to revenue suggests improved operational efficiency or economies of scale, while an increase may indicate rising input costs, laboratory inefficiencies, or supply chain challenges.
This metric captures the direct costs associated with producing and delivering the company's diagnostic tests, including...
Similar to Cost of Goods Sold (COGS) in other diagnostic firms, where peers focus on optimizing lab automation and reagent costs to improve gross margins.
ntra_segment_product_revenues_cost_of_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.23M | $76.84M | $91.28M | $102.67M | $108.76M | $115.44M | $126.77M | $147.75M | $142.81M | $146.96M | $151.04M | $158.83M | $169.85M | $167.66M | $175.96M | $184.61M | $199.53M | $207.25M | $219.23M | $245.20M |
| QoQ Change | — | +4.9% | +18.8% | +12.5% | +5.9% | +6.1% | +9.8% | +16.6% | -3.3% | +2.9% | +2.8% | +5.2% | +6.9% | -1.3% | +5.0% | +4.9% | +8.1% | +3.9% | +5.8% | +11.8% |
| YoY Change | — | — | — | — | +48.5% | +50.2% | +38.9% | +43.9% | +31.3% | +27.3% | +19.1% | +7.5% | +18.9% | +14.1% | +16.5% | +16.2% | +17.5% | +23.6% | +24.6% | +32.8% |